Microbix Biosystems, Inc.
Microbix Biosystems Inc. develops biological products and technologies. It specializes in the development of advanced biotechnologies; and markets virology and biological technologies worldwide. The company develops biological technologies, including VIRUSMAX, influenza virus yield enhancement technology; LumiSort, semen sexing technology and the thrombolytic drug; Kinlytic. It produces infectious disease antigen, including cell culture, molecular biology, and a GMP quality system. Microbix Biosystems was founded by William J. Gastle in 1988 and is headquartered in Mississauga, Canada.